Shock-wave therapy in penile rehabilitation after prostatectomy
Research type
Research Study
Full title
Investigating the effect of early low-intensity shockwave therapy (Li-ESWT) for preservation and restoration of erectile function after nerve sparing radical prostatectomy: a double-blind, randomized, 2-parallel-arm trial, using the Dornier Aries-2b Li-ESWT device on men aged 40-65 diagnosed with low-intermediate risk prostate cancer
IRAS ID
250004
Contact name
Tet Yap
Contact email
Sponsor organisation
Guy's & St Thomas' Foundation NHS Trust
Clinicaltrials.gov Identifier
Duration of Study in the UK
2 years, 0 months, 1 days
Research summary
Erectile dysfunction (ED) is reported in up to 85% of men who have undergone a radical prostatectomy for prostate cancer. At present, this debilitating consequence of surgery is managed in a step-wise approach including oral medication, injections and in severe cases, insertion of a penile prosethesis. A few small studies have shown that low-intensity shockwave therapy may improve sexual performance in men with ED. However, the optimal dosage and length of treatment is yet to be determined. We propose a randomised trial evaluating the efficacy and safety of low-intensity shockwave therapy in men with ED following prostatectomy surgery.
REC name
London - Queen Square Research Ethics Committee
REC reference
19/LO/1534
Date of REC Opinion
19 Nov 2019
REC opinion
Further Information Favourable Opinion